Curis (CRIS) Revenue & Revenue Breakdown
Curis Revenue Highlights
Latest Revenue (Y)
$10.02M
Latest Revenue (Q)
$2.55M
Main Segment (Y)
Gross Royalty Revenue
Curis Revenue by Period
Curis Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $10.02M | -1.37% |
2022-12-31 | $10.16M | -4.57% |
2021-12-31 | $10.65M | -1.72% |
2020-12-31 | $10.84M | 8.31% |
2019-12-31 | $10.00M | -4.07% |
2018-12-31 | $10.43M | 5.35% |
2017-12-31 | $9.90M | 31.50% |
2016-12-31 | $7.53M | -4.46% |
2015-12-31 | $7.88M | -19.96% |
2014-12-31 | $9.84M | -34.39% |
2013-12-31 | $15.00M | -11.61% |
2012-12-31 | $16.97M | 14.97% |
2011-12-31 | $14.76M | -7.73% |
2010-12-31 | $16.00M | 86.26% |
2009-12-31 | $8.59M | 2.67% |
2008-12-31 | $8.37M | -48.95% |
2007-12-31 | $16.39M | 9.73% |
2006-12-31 | $14.94M | 148.83% |
2005-12-31 | $6.00M | 21.20% |
2004-12-31 | $4.95M | -55.17% |
2003-12-31 | $11.05M | -39.92% |
2002-12-31 | $18.39M | 1592.64% |
2001-12-31 | $1.09M | 8.97% |
2000-12-31 | $997.08K | -68.96% |
1999-12-31 | $3.21M | - |
Curis Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $2.55M | 22.05% |
2024-03-31 | $2.09M | -22.63% |
2023-12-31 | $2.70M | -4.84% |
2023-09-30 | $2.83M | 28.95% |
2023-06-30 | $2.20M | -4.35% |
2023-03-31 | $2.30M | -20.44% |
2022-12-31 | $2.89M | 2.19% |
2022-09-30 | $2.83M | 18.05% |
2022-06-30 | $2.39M | 16.33% |
2022-03-31 | $2.06M | -34.39% |
2021-12-31 | $3.13M | 3.16% |
2021-09-30 | $3.04M | 32.94% |
2021-06-30 | $2.29M | 4.43% |
2021-03-31 | $2.19M | -27.61% |
2020-12-31 | $3.02M | 10.28% |
2020-09-30 | $2.74M | 16.19% |
2020-06-30 | $2.36M | -12.88% |
2020-03-31 | $2.71M | -17.58% |
2019-12-31 | $3.29M | 15.09% |
2019-09-30 | $2.86M | 36.39% |
2019-06-30 | $2.09M | 18.51% |
2019-03-31 | $1.77M | -35.86% |
2018-12-31 | $2.75M | -3.23% |
2018-09-30 | $2.85M | 20.74% |
2018-06-30 | $2.36M | -4.46% |
2018-03-31 | $2.47M | -24.34% |
2017-12-31 | $3.26M | 33.47% |
2017-09-30 | $2.44M | 18.58% |
2017-06-30 | $2.06M | -3.28% |
2017-03-31 | $2.13M | -9.78% |
2016-12-31 | $2.36M | 34.28% |
2016-09-30 | $1.76M | 4.70% |
2016-06-30 | $1.68M | -2.66% |
2016-03-31 | $1.73M | -17.52% |
2015-12-31 | $2.09M | 2.33% |
2015-09-30 | $2.04M | -1.80% |
2015-06-30 | $2.08M | 25.58% |
2015-03-31 | $1.66M | -16.78% |
2014-12-31 | $1.99M | 12.91% |
2014-09-30 | $1.76M | -63.24% |
2014-06-30 | $4.80M | 273.75% |
2014-03-31 | $1.28M | -15.71% |
2013-12-31 | $1.52M | -78.84% |
2013-09-30 | $7.20M | 33.26% |
2013-06-30 | $5.40M | 520.17% |
2013-03-31 | $871.43K | -48.33% |
2012-12-31 | $1.69M | 191.89% |
2012-09-30 | $577.76K | -86.72% |
2012-06-30 | $4.35M | -57.98% |
2012-03-31 | $10.36M | -26.49% |
2011-12-31 | $14.09M | 9476.44% |
2011-09-30 | $147.12K | -62.55% |
2011-06-30 | $392.87K | 194.20% |
2011-03-31 | $133.54K | 33.16% |
2010-12-31 | $100.29K | -96.91% |
2010-09-30 | $3.24M | 3187.21% |
2010-06-30 | $98.63K | -99.21% |
2010-03-31 | $12.56M | 628.34% |
2009-12-31 | $1.72M | 125.30% |
2009-09-30 | $765.31K | 1109.73% |
2009-06-30 | $63.26K | -98.95% |
2009-03-31 | $6.04M | 94.46% |
2008-12-31 | $3.10M | 3479.87% |
2008-09-30 | $86.72K | -97.21% |
2008-06-30 | $3.11M | 50.31% |
2008-03-31 | $2.07M | -82.00% |
2007-12-31 | $11.48M | - |
Curis Revenue Breakdown
Curis Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Gross Royalty Revenue | $9.90M | $10.28M | $10.40M | - | - |
Other Revenue | - | - | $1.00K | $214.00K | - |
Contra Revenue | - | $-116.00K | $-101.00K | $-103.00K | - |
Royalty | - | - | $10.75M | $10.72M | - |
Research And Development, Net | - | - | - | - | $100.00K |
Latest
Quarterly Revenue by Product
Product/Service | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Dec 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Royalty Revenue | $2.60M | $2.70M | $2.30M | $2.30M | $2.90M | $2.84M | $2.47M | $2.06M | $3.10M | $3.06M | $2.35M | $2.19M | $2.72M | $2.45M | $2.52M | $2.91M | $2.14M | $2.14M | $2.80M | - |
Contra Revenue | - | - | - | - | $-14.00K | $-18.00K | $-81.00K | $-3.00K | $-19.00K | $-63.00K | $2.00K | $-22.00K | $22.00K | $-86.00K | $-17.00K | $-50.00K | $-48.00K | $-370.00K | - | - |
Other Revenue | - | - | - | - | - | - | - | - | $1.00K | - | $3.00K | - | - | $211.00K | - | - | - | - | - | - |
Latest
Curis Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ADAP | Adaptimmune Therapeutics | $60.28M | $128.23M |
PIRS | Pieris Pharmaceuticals | $42.81M | - |
CRIS | Curis | $10.02M | $2.55M |
MREO | Mereo BioPharma Group | $10.00M | - |
AFMD | Affimed | $8.28M | $155.00K |
CRVS | Corvus Pharmaceuticals | - | - |
APTO | Aptose Biosciences | - | - |
XFOR | X4 Pharmaceuticals | - | $560.00K |
PDSB | PDS Bio | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
INZY | Inozyme Pharma | - | - |
LPTX | Leap Therapeutics | - | - |
ALRN | Aileron Therapeutics | - | - |
TERN | Terns Pharmaceuticals | - | - |
ARTL | Artelo Biosciences | - | - |